NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $12.42 -0.28 (-2.20%) Closing price 03:59 PM EasternExtended Trading$12.42 +0.01 (+0.04%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About InMode Stock (NASDAQ:INMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InMode alerts:Sign Up Key Stats Today's Range$12.40▼$12.6950-Day Range$12.70▼$14.9052-Week Range$12.40▼$16.67Volume706,622 shsAverage Volume781,162 shsMarket Capitalization$713.90 millionP/E Ratio10.26Dividend YieldN/APrice Target$16.33Consensus RatingHold Company Overview InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications. The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments. InMode sells its systems to physicians and other medical professionals, serving customers in the United States and international markets through a combination of direct sales and distribution partners. Founded in 2008, InMode is headquartered in Yokneam, Israel. The company was co-founded by Moshe Mizrahy, who has served as its chief executive officer, and Dr. Michael Kreindel.AI Generated. May Contain Errors. Read More InMode Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreINMD MarketRank™: 2.1329772665 of 5 starsInMode scored higher than 43% of companies evaluated by MarketBeat, and ranked 603rd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.Upside PotentialInMode has a consensus price target of $16.33, representing about 30.3% upside from its current price of $12.54.Amount of Analyst CoverageInMode has only been the subject of 2 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 10.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.39.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 10.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.64.Price to Book Value per Share RatioInMode has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.24% of the float of InMode has been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 4.79.Change versus previous monthShort interest in InMode has recently increased by 2.33%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. News and Social Media1.1 / 5News Sentiment-0.27 News SentimentInMode has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for InMode this week, compared to 3 articles on an average week. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by Insiders6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INMD Stock News HeadlinesHead to Head Review: InMode (INMD) versus The CompetitionNovember 17 at 9:48 AM | americanbankingnews.comCanaccord Genuity Keeps Their Hold Rating on InMode (INMD)November 16, 2026 | theglobeandmail.comWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 20 at 1:00 AM | Porter & Company (Ad)InMode Reports Third-Quarter 2026 Revenue of $92.1 MillionNovember 14, 2026 | theglobeandmail.comInMode (NASDAQ:INMD) Stock Price Target Lowered at Robert W. BairdNovember 13, 2026 | americanbankingnews.comInMode: High Potential Upside On Conservative Assumptions, Upgrading To HoldNovember 11, 2026 | seekingalpha.comInmode Q3 Income DeclinesNovember 11, 2026 | rttnews.comInMode Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 11, 2026 | marketscreener.comMSee More Headlines INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $14.69 on January 1st, 2026. Since then, INMD stock has decreased by 14.7% and is now trading at $12.5350. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) announced its quarterly earnings data on Wednesday, November, 11th. The healthcare company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.05. InMode's revenue for the quarter was down 1.1% on a year-over-year basis. When did InMode's stock split? Shares of InMode split on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were payable to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does InMode have any subsidiaries? InMode subsidiaries include these companies: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? Top institutional shareholders of InMode include State Street Corp (1.25%), Lind Value II ApS (0.75%), Alberta Investment Management Corp (0.34%) and CWA Asset Management Group LLC (0.30%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), PayPal (PYPL), Tesla (TSLA), CrowdStrike (CRWD), Block (XYZ) and Salesforce (CRM). Company Calendar Last Earnings11/11/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (57m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 INMD's financial health is in the Red zone, according to TradeSmith. INMD has been in this zone for over 57 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:INMD CIK1742692 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees660Year Founded2008Price Target and Rating Average Price Target for InMode$16.33 High Price Target$19.00 Low Price Target$15.00 Potential Upside/Downside+31.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$1.21 Trailing P/E Ratio10.26 Forward P/E RatioN/A P/E GrowthN/ANet Income$93.83 million Net Margins19.94% Pretax Margin23.43% Return on Equity11.55% Return on Assets10.18% Debt Debt-to-Equity RatioN/A Current Ratio8.58 Quick Ratio7.28 Sales & Book Value Annual Sales$370.49 million Price / Sales1.93 Cash Flow$1.44 per share Price / Cash Flow8.63 Book Value$11.33 per share Price / Book1.10Miscellaneous Outstanding Shares57,480,000Free Float53,503,000Market Cap$713.90 million OptionableOptionable Beta1.98 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:INMD) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredBlack Friday Special: Buy These Stocks Before Nov. 30thKeith Kaplan's firm has invested $17 million in its own AI research and tools, and 180,000 people worldwide no...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.